In a mouse model of lung adenocarcinoma, RIPK4 suppression resulted in cancer dedifferentiation and in human lung adenocarcinoma patient low RIPK4 mRNA levels were associated with poor tumor differentiation and reduced overall survival [169]. This evidence concerns the gene RIPK4 and neoplasm.